Bromide

Bromide

SCHEMBL7402182

Br.N=C(N)NCCCC(C=CC(=O)O)NC(=O)[C@@H](N)Cc1ccc(C(=O)N2CCOCC2)cc1

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CTSL P07711 2/20 0.42
HRH3 Q9Y5N1 2/20 0.41
ACACB O00763 2/20 0.41
CTSB P07858 1/20 0.37
NPY4R P50391 6/20 0.36
NPY1R P25929 4/20 0.36
GAA P10253 1/20 0.36
NPY2R P49146 2/20 0.36
NPY5R Q15761 2/20 0.36
HPGD P15428 1/20 0.35
MASP2 O00187 1/20 0.35
F2 P00734 1/20 0.35
TACR2 P21452 2/20 0.35
CAPN1 P07384 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL7354482 0.88 CTSL (0.45) CTSLHRH3ACACBCTSBGAA
SCHEMBL7359178 0.83 DPP8 (0.46) CTSL
Bromide SCHEMBL7402178 0.81 CTSL (0.63) CTSLCTSBTACR2
Bromide SCHEMBL7402175 0.81 CTSL (0.63) CTSLCTSBTACR2
Bromide SCHEMBL7353740 0.81 CTSL (0.63) CTSLCTSBTACR2
Bromide SCHEMBL7353735 0.81 CTSL (0.63) CTSLCTSBTACR2
SCHEMBL7354030 0.79 CTSL (0.59) CTSLACACBCTSBGAAMASP2
Bromide SCHEMBL7357091 0.72 CTSB (0.74) CTSLCTSBTACR2
Bromide SCHEMBL7357088 0.72 CTSB (0.74) CTSLCTSBTACR2
SCHEMBL25690544 0.71 NPY4R (0.52) NPY4RNPY1RNPY2RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0756625-A4 IRREVERSIBLE CYSTEINE PROTEASE INHIBITORS CONTAINING VINYL GROUPS CONJUGATED TO ELECTRON WITHDRAWING GROUPS ARRIS PHARM CORP (US) 1999-07-28 EP claimed
EP-0756625-A1 IRREVERSIBLE CYSTEINE PROTEASE INHIBITORS CONTAINING VINYL GROUPS CONJUGATED TO ELECTRON WITHDRAWING GROUPS ARRIS PHARMACEUTICAL CORPORATION (US) 1997-02-05 EP claimed
WO-1995023222-A1 IRREVERSIBLE CYSTEINE PROTEASE INHIBITORS CONTAINING VINYL GROUPS CONJUGATED TO ELECTRON WITHDRAWING GROUPS KHEPRI PHARMACEUTICALS, INC. (US) 1995-08-31 WO claimed